FRAMEWORK: VV STUDY EVIDENCE MATRIX v1.0
A study is not useful just because it exists.
Some studies change practice. Some clarify risk. Some are early signals. Some are mostly mechanism. The VV Study Evidence Matrix turns research into public-facing context without pretending every paper proves more than it does.
What this framework is for
VV Study Evidence Matrix v1.0 is for translating papers, labels, registries, guidance, and reviews into clear public context while keeping the claim bounded by design, population, endpoint, and limitations.
What the score does not mean
It does not mean a study applies to everyone.
It does not erase adverse events, cost, access, or adherence problems.
It does not turn mechanisms, surrogate endpoints, or indirect evidence into outcome proof.
Score bands
The paired VV Evidence Utility Score uses 85-100 Strong Public Evidence, 70-84 Useful Public Evidence, 55-69 Limited Public Evidence, 40-54 Early Signal, and below 40 Weak or Indirect Evidence.
Gates and caps
Claims stay bounded by population, design, endpoint, duration, and limitations.
Animal, cell, registry, and abstract-only evidence cannot carry broad clinical claims.
Safety gaps require explicit uncertainty.
Goal of the Matrix
The goal is not to worship abstracts. The goal is to help readers understand what a study can and cannot support.
Matrix Dimensions
Evidence tier
Design quality
Population fit
Endpoint relevance
Limitations transparency
Safety and adverse event usefulness
Source and publication strength
Population Fit
A study is strongest for the people actually studied. If a trial studied adults with obesity and cardiovascular disease, it should not be casually generalized to healthy young athletes.
Endpoint Relevance
Clinical outcomes usually matter more than surrogate markers. Mortality, hospitalization, symptoms, function, remission, adverse events, and quality of life usually carry more public meaning than isolated lab changes.
Common Limitations
Short duration
Small sample size
Narrow population
Surrogate endpoint
Observational design
Confounding
Industry funding
Limited generalizability
VV Study Evidence Matrix v1.0
Use the Viral Vitalism framework system to make health claims clearer, more contextual, and easier to evaluate.
Viral Vitalism is an educational publication, not medical advice.